Virus-like particles with genetically defined envelope proteins were generated from cDNA in order to examine the requirement of Sendai virus haemagglutinin-neuraminidase (HN) protein for particle formation, and the role of fusion protein (F) in receptor binding and membrane fusion. Characterization of particles devoid of HN protein showed that particle formation was unimpaired by the absence of HN protein, indicating that HN protein is dispensable for virus assembly and budding. Infection studies further demonstrated that virus adsorption and penetration can be mediated solely by the F protein when the human asialoglycoprotein receptor is present at the surface of host cells.
efficiently synthesized on cellular membranes but is degraded during transport to the cell surface (Tuffereau et al., 1985) . Mutant virus grown at restrictive temperature exhibits an altered cell tropism -ts271 no longer infects conventional SeV host cells such as HeLa, MDBK and MDCK cells ; however, it still infects human hepatoma HepG2 cells. Biochemical characterization of HepG2 infection suggested that ts271 binds via the F protein to the asialoglycoprotein receptor (ASGP-R) on HepG2 followed by F-mediated membrane fusion (Markwell et al., 1985) . Similar results were obtained with systems where SeV envelopes were reconstituted containing purified F protein (Bagai et al., 1993) . It was found that these F virosomes could fuse to cells when ASGP-R was present on the target membrane.
To investigate the requirement of HN protein for the transport of the nucleocapsid toward the cell surface and for virus assembly in general, reverse genetics techniques were used to generate genetically defined virus-like particles (VLPs) that lack the HN protein. Infection studies with these HNdeficient particles in combination with two host cell types, which differ only with respect to ASGP-R expression, allow a precise re-examination of the role of the viral F protein and ASGP-R in the infection process. The use of genetically defined cell-grown VLPs in these infection studies avoids potential drawbacks that might result from the sometimes leaky phenotype of temperature-sensitive mutants. They also eliminate such factors as method of reconstitution and size of virosomes, which have been shown to influence whether or not transfer of F-virosome contents into cells can be mediated by forms of attachment to the target cell other than HN (Bagai et al., 1993 ; Citovsky et al., 1986 ; Nakanishi et al., 1982) .
For the generation of infectious defective SeV particles entirely from cloned cDNA, the plasmid pSeV-CAT ( Fig. 1) was constructed with PCR fusion techniques (Horton, 1993) . Transcription of pSeV-CAT by T7 polymerase followed by ribozyme cleavage results in an RNA (SeV : CAT) which corresponds to an SeV antigenome in which all viral coding and intercistronic regions are replaced by the chloramphenicol acetyltransferase (CAT) coding sequence. The length of Fig. 1 . Schematic presentation of pSeV-CAT containing the cDNA insert which specifies SeV : CAT, the SeV antigenome RNA analogue. The insert of the pUC19 backbone contains the SeV leader (SeV ld, nt 1-119) and trailer region (SeV tr, nt 15243-15384) flanking the CAT ORF. Transcription from the T7 promoter (T7 prom.) initiates (j1) with the precise 5h-terminal nucleotide of SeV antigenome, proceeds beyond the 84 nt of the hepatitis delta virus antigenomic ribozyme (δ riboz. ; Perrotta & Been, 1991) and stops at the bacteriophage T7 terminator sequence (T7 term.). The site-specific endonucleolytic activity of the ribozyme produces the exact viral 3h end of SeV : CAT.
SeV : CAT is a multiple of six and the mini-antigenome should be rescued into transmissible particles when the SeV genes required for the replicative cycle are co-expressed in the cell. For the synthesis of SeV proteins in transfected cells, the coding regions of the genes N, P, M, F, HN and L, cloned in this laboratory from SeV (Fushimi strain), were inserted into vector pTM1 (Moss et al., 1990) to form the six plasmids pTM-N, -P, -M, -F, -HN and -L, and expressed with the vaccinia vTF7-3 system (Fuerst et al., 1986) . For the production of VLPs containing SeV : CAT, HeLa cells were grown in 75 cm# Roux bottles to 60 % confluency and infected with vTF7-3 at an m.o.i. of 3. To generate VLPs that contain the HN protein in their envelope (VLPHN + ), the cells were transfected 1 h postinfection (p.i.) with a plasmid mixture containing 3 µg pTM-N, 8 µg pTM-P, 4 µg pTM-M, 2n8 µg pTM-F, 2n8 µg pTM-HN, 1n6 µg pTM-L and 20 µg pSeV-CAT using LipofectAce according to the manufacturer's protocol (Gibco BRL). For production of HN-deficient virions (VLPHN − ) pTM-HN was omitted from the plasmid mixture, and for the negative control pTM-M was absent from the transfection mix. Medium was replaced 7 h p.i. with serum-free medium containing 100 µg\ml cytosine β--arabinofuranoside (AraC). After 48 h, acetylated trypsin (4 µg\ml) was added to cleave the F ! protein and the supernatant was used for infection experiments. For characterization of the particles by electron microscopy, Western and Northern blotting, supernatants of transfected cells were pooled without trypsin treatment and the VLPs were purified on sucrose gradients as described previously (Homann et al., 1991) .
For electron microscopy, purified cell supernatants from the two experimental settings were prepared as described by Neubert et al. (1983) . Examination under the electron microscope revealed that VLPs are present in both preparations. This demonstrates that formation of virus particles can occur in the absence of HN protein. The morphology of VLPHN + particles ( Fig. 2 b) is similar to that of SeV wt particles (Fig. 2 a) , which appear to be spherical and pleomorphic in size, with a diameter ranging from 150-350 nm (Lamb & Kolakofsky, 1996) . VLPHN − particles (Fig. 2 c) , by contrast, obviously tend to aggregate, and the viral membrane appears to contain irregularly located spikes and to lack a basal ring. To examine the protein composition of the particles, proteins of VLPHN + and VLPHN − purified from the supernatants of about 7i10' cells as well as SeV wt proteins were analysed by immunoblotting as described previously (Willenbrink & Neubert, 1994) . As expected, no HN protein could be detected for VLPHN − using HN-specific monoclonal antibodies (Fig. 2 d) , whereas HN protein bands were obtained for the SeV wt and VLPHN + preparations. Detection of the F protein with Fspecific monoclonal antibodies (Fig. 2 e) resulted in a significantly stronger signal for the VLPHN − preparation compared to VLPHN + . The increased signal intensity is partly due to the slightly elevated particle amount in the VLPHN − preparation (see Fig. 2 g ). There is no detectable difference in particle size between VLPHN + and VLPHN − under the electron microscope which might account for a larger envelope of VLPHN − particles, thereby increasing the amount of F protein. Reduced or missing expression of SeV HN protein also does not influence the expression of F protein, at least with the vaccinia virus expression system, as shown by Bousse et al. (1997) . The absence of HN protein obviously leads to an increased incorporation of F protein into viral envelopes. Similar observations have been made in studies of reconstituted F virosomes (Bagai et al., 1993) . When the complete protein composition of the VLPs is examined with polyclonal SeVspecific antibodies (Fig. 2 f) , major structural components such as the capsid proteins N and P can be detected, as in the wildtype virus, confirming that the structure of VLPs reflects that of SeV wt.
To investigate further whether packaging efficacy of SeV : CAT nucleocapsids into particles is influenced by the presence of HN protein, RNA from the supernatant of 7i10' transfected cells from the VLPHN + and VLPHN − preparations was isolated using standard procedures and quantified by Northern blot hybridization (Sambrook et al., 1989) . Hybridization with a CAT-specific probe resulted in a slightly stronger signal for VLPHN − RNA compared with the signal obtained for VLPHN + RNA (Fig. 2 g) . The amounts of VLPHN + and VLPHN − particles in the cell supernatants are therefore similar, and the budding efficacy of the VLPs is not influenced 6 transfected cells was isolated, separated by gel electrophoresis and transferred to nylon membranes. The RNA was hybridized with labelled RNA complementary to the coding strand of CAT ORF (mRNA polarity). As positive control, genomic SeV : CAT RNA, made by in vitro run-off transcription, was analysed in parallel. Probe labelling and detection were carried out with DIG RNA labelling kit and DIG luminescence detection kit (Boehringer).
by HN protein. The intracellular replication of SeV : CAT nucleocapsids is dependent only upon the proteins of the polymerase complex (data not shown). From the given results it can be concluded that the experimental design allows the production of both VLPHN + and VLPHN − entirely from cloned cDNAs. With the generation of VLPHN − particles from cDNA it could be clearly demonstrated for the first time that SeV assembly in general does not require the presence of any HN protein.
The generation of defined virus particles containing solely F glycoprotein in their envelope allowed us to examine the role of F protein in virus-cell interaction : if VLPHN − are infectioncompetent particles, incubation of permissive cells with VLPHN − should result in transmission of genomic SeV : CAT RNA and subsequent production of CAT enzyme when an SeV polymerase complex is provided by simultaneous SeV wt infection. NIH 3T3 (Swiss mouse embryo cells) or 1-7-1 cells, i.e. NIH 3T3 cells stably expressing ASGP-R on the cell surface (Shia & Lodish, 1989) , were used for infection. Cells grown in 35 mm diameter culture dishes to 60-80 % confluency were incubated with 100 µl trypsin-activated supernatant of VLPproducing cells and were simultaneously infected with SeV wt (m.o.i. l 3). After 30 min at 37 mC cells were washed three times with serum-free medium (M199, Gibco-BRL) and incubated with growth medium (M199 supplemented with 10 % foetal calf serum) for 24 h. Cells were harvested with reporter lysis buffer (Promega) according to the manufacturer's instructions. CAT assays were carried out using standard procedures adapted from Gorman et al. (1982) with the modifications of Conzelmann & Schnell (1994) . The results Fig. 3 . Transmission of SeV : CAT by VLPs to 3T3 or 1-7-1 cells. Cells were infected with SeV wt and VLPHN + and VLPHN − , respectively, and CAT activity was measured in the cell extracts as described in the text. For treatment with V. cholerae sialidase cells were incubated for 1 h at 37 mC with 7 mU sialidase, and washed twice with serum-free medium prior to infection. Trypsin treatment was as described above. In lanes 4 and 5, VLPHN − were incubated with monoclonal F (lane 4) and HN antibodies (lane 5) prior to infection, as described in the text. CAT activity signals in lanes 6 and 7 were obtained from a different experiment and brought to scale. When, for a negative control, pTM-M plasmid was omitted from the plasmid mixture used for the generation of VLPs, there was no measurable CAT activity (data not shown).
show that VLPHN + successfully infects 3T3 and 1-7-1 cells (Fig. 3, lanes 8 and 9) . Infection is strictly dependent upon trypsin cleavage of the F ! precursor (Lamb & Kolakofsky, 1996) into the active F " and F # subunits (lane 12). Treatment of 3T3 cells with Vibrio cholerae sialidase, which hydrolyses endogenous cell surface sialoglycoconjugates (Markwell & Paulson, 1980) , renders the cells resistant to VLPHN + infection (lane 10). Sialidase-treated 1-7-1 cells, by contrast, can still be infected by VLPHN + (lane 11) indicating that there is an alternative route of entry for the particles via ASGP-R. Infection of 3T3 cells is absolutely dependent upon HN in the envelope since VLPHN − , which lack the HN protein, cannot infect 3T3 cells (lane 2). However, expression of ASGP-R protein on the surface of 3T3 cells (1-7-1) renders these cells susceptible to VLPHN − infection : incubation of 1-7-1 cells with VLPHN − leads to a CAT activity (lane 1 or 6) similar to that obtained for infection of 3T3 with VLPHN + (lane 8). F protein contains a terminal galactose moiety (Yoshima et al., 1981) and ASGP-R is able to bind proteins with terminal galactose residues. Adsorption of VLPHN − to ASGP-R and subsequent penetration of 1-7-1 cells is mediated by the F protein, since incubation of VLPHN − for 2 h with 12 µg purified monoclonal F antibodies completely blocks the infection of 1-7-1 cells (lane 4). As a control, incubation of VLPHN − with monoclonal HN antibodies does not influence infection of 1-7-1 cells (lane 5). Internalization of the particles into host cells is achieved by F protein of the VLPs and not by the co-infecting SeV wt, since neither VLPHN + nor VLPHN − with an inactive F ! protein can infect 3T3 or 1-7-1 cells (lanes 12 and 7). Treatment of 1-7-1 cells with sialidase before infection with VLPHN − reduces the CAT activity slightly (lane 3). This is congruent with the nature of the ASGP-R, which is itself a glycoprotein (Paulson et al., 1977) , and incubation with sialidase generates terminal galactose residues which compete with exogenous ligands like VLPHN − for the binding sites (Stockert et al., 1977) . Infection of 1-7-1 cells by VLPHN − also shows that F protein alone is sufficient for fusion of the particle membrane with the host cell membrane. F protein-mediated membrane fusion, however, seems to be enhanced by the HN protein, since signal intensity for VLPHN + infecting 1-7-1 cells (lane 9) is stronger than that for VLPHN − (lane 1), which complies with results obtained on the fusion rates of reconstituted SeV envelopes (Bagai et al., 1993) . In previous reports (Stricker & Roux, 1991 , and references cited therein) it has been demonstrated for a variety of paramyxoviruses that co-expression of HN and F and physical association of the glycoproteins (Yao et al., 1997 ) is necessary to induce syncytium formation. However, the fusion of viruses to cells and cell-cell fusion seem to be related but different processes : it has been shown for cell-cell fusion that receptor density (Moscona & Peluso, 1992) ; lateral mobility of F and HN protein in the plasma membrane (Henis et al., 1989) ; and accumulation of the glycoprotein in regions of cell-cell contact (Aroeti & Henis, 1991) are important factors for cell-cell fusion. The present results with VLPHN − clearly demonstrate that F protein in the viral envelope alone is sufficient for the adsorption and fusion process of VLPs on ASGP-R expressing cells. The efficacy with which VLPHN − infect ASGP-Rexpressing 1-7-1 cells is almost comparable to that of VLPHN + infection of 3T3 cells. F-mediated infection of cells expressing ASGP-R therefore seems to be an efficient alternative route of entry for SeV in some tissues, which by-passes the interaction of HN with widespread sialoglycolipids. 
